Diagnosi prenatale ed ecografia in gravidanza - Age.Na.S.

Capitolo 9 • Screening delle malattie metaboliche 199
21. Jakobs C, Dorland L, Wikkerink B, et al. Stable isotope
dilution analysis of succinylacetone using electron capture
negative ion mass fragmentography: an accurate approach
to the pre- and neonatal diagnosis of hereditary tyrosinemia
type I. Clin Chim Acta. 1988 Feb 15;171(2-3):223-31.
22. Jakobs C, Stellaard F, Kvittingen EA, et al. First-trimester
prenatal diagnosis of tyrosinemia type I by amniotic
fluid succinylacetone determination. Prenat Diagn. 1990
Feb;10(2):133-4.
23. Kamoun PP, Chadefaux B. Eleventh week amniocentesis
for prenatal diagnosis of some metabolic diseases. Prenat
Diagn. 1991 Sep;11(9):691-6.
24. Kelley RI. Prenatal detection of Canavan disease by
measurement of N-acetyl-L-aspartate in amniotic fluid. J
Inherit Metab Dis. 1993;16(5):918-9.
25. Kleijer WJ, Garritsen VH, Linnebank M, et al. Clinical,
enzymatic, and molecular genetic characterization of a
biochemical variant type of argininosuccinic aciduria:
prenatal and postnatal diagnosis in five unrelated families.
J Inherit Metab Dis. 2002 Sep;25(5):399-410.
26. Kumps A, Vamos E, Mardens Y, et al. Assessment of an
electron-impact GC-MS method for organic acids and
glycine conjugates in amniotic fluid. J Inherit Metab Dis.
2004;27(5):567-79.
27. Mandell R, Packman S, Laframboise R, et al. Use
of amniotic fluid amino acids in prenatal testing for
argininosuccinic aciduria and citrullinaemia. Prenat Diagn.
1996 May;16(5):419-24.
28. Merinero B, Pérez-Cerdá C, Garcia MJ, et al. Reliability
of biochemical parameters used in prenatal diagnosis of